Neuroprotective role of Nrf2 for retinal ganglion cells in ischemia-reperfusion

Journal of Neurochemistry

Volumn 133, Issue 2, 2015, Pages 233-241

  Xu, Zhenhua ^a   Cho, Hongkwan ^a   Hartsock, Matthew J ^a   Mitchell, Katherine L ^a   Gong, Junsong ^a   Wu, Lijuan ^a   Wei, Yanhong ^a   Wang, Shuang ^a   Thimmulappa, Rajesh K ^b   Sporn, Michael B ^c   Biswal, Shyam ^b   Welsbie, Derek S ^a   Duh, Elia J ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b The Johns Hopkins University   (United States)

^c DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

ganglion cell; ischemia; Nrf2; oxidative stress; retina

Indexed keywords

2 CYANO 3,12 DIOXOOLEANA 1,9 DIEN 28 IMIDAZOLIDE; REACTIVE OXYGEN METABOLITE; TRANSCRIPTION FACTOR NRF2; TRITERPENOID; UNCLASSIFIED DRUG; 1-(2-CYANO-3,12-DIOXOOLEANA-1,9-DIEN-28-OYL) IMIDAZOLE; IMIDAZOLE DERIVATIVE; NFE2L2 PROTEIN, MOUSE; OLEANOLIC ACID; SMALL INTERFERING RNA; TERT BUTYL HYDROPEROXIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NERVE CELL CULTURE; NERVE CELL DEGENERATION; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN FUNCTION; REPERFUSION INJURY; RETINA GANGLION CELL; RETINA ISCHEMIA; ANALOGS AND DERIVATIVES; ANIMAL; C57BL MOUSE; CELL CULTURE; CYTOLOGY; DISEASE MODEL; DRUG EFFECTS; GENETICS; ISCHEMIA; METABOLISM; PATHOLOGY; RETINA; TRANSGENIC MOUSE;

MUS;

ANIMALS; CELL SURVIVAL; CELLS, CULTURED; DISEASE MODELS, ANIMAL; DOWN-REGULATION; IMIDAZOLES; IN VITRO TECHNIQUES; ISCHEMIA; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NF-E2-RELATED FACTOR 2; OLEANOLIC ACID; REACTIVE OXYGEN SPECIES; REPERFUSION INJURY; RETINA; RETINAL GANGLION CELLS; RNA, SMALL INTERFERING; TERT-BUTYLHYDROPEROXIDE;

EID: 84926675634     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/jnc.13064     Document Type: Article

References (25)

1. Bastianetto S., and, Quirion R., (2004) Natural antioxidants and neurodegenerative diseases. Front Biosci. 9, 3447-3452.
2. Calkins M. J., Johnson D. A., Townsend J. A., et al,. (2009) The Nrf2/ARE pathway as a potential therapeutic target in neurodegenerative disease. Antioxid. Redox Signal. 11, 497-508.
3. Gan L., and, Johnson J. A., (2014) Oxidative damage and the Nrf2-ARE pathway in neurodegenerative diseases. Biochim. Biophys. Acta 1842, 1208-1218.
4. Himori N., Yamamoto K., Maruyama K., Ryu M., Taguchi K., Yamamoto M., and, Nakazawa T., (2013) Critical role of Nrf2 in oxidative stress-induced retinal ganglion cell death. J. Neurochem. 127, 669-680.
5. Inoue Y., Shimazawa M., Nakamura S., Imamura T., Sugitani S., Tsuruma K., and, Hara H., (2014) Protective effects of placental growth factor on retinal neuronal cell damage. J. Neurosci. Res. 92, 329-337.
6. Johnson J. A., Johnson D. A., Kraft A. D., Calkins M. J., Jakel R. J., Vargas M. R., and, Chen P. C., (2008) The Nrf2-ARE pathway: an indicator and modulator of oxidative stress in neurodegeneration. Ann. N. Y. Acad. Sci. 1147, 61-69.
7. Kensler T. W., Wakabayashi N., and, Biswal S., (2007) Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway. Annu. Rev. Pharmacol. Toxicol. 47, 89-116.
8. Kim B. J., Braun T. A., Wordinger R. J., and, Clark A. F., (2013) Progressive morphological changes and impaired retinal function associated with temporal regulation of gene expression after retinal ischemia/reperfusion injury in mice. Mol. Neurodegener. 8, 21.
9. Koriyama Y., Chiba K., Yamazaki M., Suzuki H., Muramoto K., and, Kato S., (2010) Long-acting genipin derivative protects retinal ganglion cells from oxidative stress models in vitro and in vivo through the Nrf2/antioxidant response element signaling pathway. J. Neurochem. 115, 79-91.
10. Koriyama Y., Nakayama Y., Matsugo S., and, Kato S., (2013) Protective effect of lipoic acid against oxidative stress is mediated by Keap1/Nrf2-dependent heme oxygenase-1 induction in the RGC-5 cellline. Brain Res. 1499, 145-157.
11. Korthuis R. J., and, Granger D. N., (1993) Reactive oxygen metabolites, neutrophils, and the pathogenesis of ischemic-tissue/reperfusion. Clin. Cardiol. 16, I19-I26.
12. Liby K., Hock T., Yore M. M., et al,. (2005) The synthetic triterpenoids, CDDO and CDDO-imidazolide, are potent inducers of heme oxygenase-1 and Nrf2/ARE signaling. Cancer Res. 65, 4789-4798.
13. Liby K. T., Yore M. M., and, Sporn M. B., (2007) Triterpenoids and rexinoids as multifunctional agents for the prevention and treatment of cancer. Nat. Rev. Cancer 7, 357-369.
14. Liu Y., Tang L., and, Chen B., (2012) Effects of antioxidant gene therapy on retinal neurons and oxidative stress in a model of retinal ischemia/reperfusion. Free Radic. Biol. Med. 52, 909-915.
15. McCord J. M., (1985) Oxygen-derived free radicals in postischemic tissue injury. N. Engl. J. Med. 312, 159-163.
16. Nagai N., Thimmulappa R. K., Cano M., et al,. (2009) Nrf2 is a critical modulator of the innate immune response in a model of uveitis. Free Radic. Biol. Med. 47, 300-306.
17. Osborne N. N., Casson R. J., Wood J. P., Chidlow G., Graham M., and, Melena J., (2004) Retinal ischemia: mechanisms of damage and potential therapeutic strategies. Prog. Retin. Eye Res. 23, 91-147.
18. Pitha-Rowe I., Liby K., Royce D., and, Sporn M., (2009) Synthetic triterpenoids attenuate cytotoxic retinal injury: cross-talk between Nrf2 and PI3K/AKT signaling through inhibition of the lipid phosphatase PTEN. Invest. Ophthalmol. Vis. Sci. 50, 5339-5347.
19. Tan E., Ding X. Q., Saadi A., Agarwal N., Naash M. I., and, Al-Ubaidi M. R., (2004) Expression of cone-photoreceptor-specific antigens in a cell line derived from retinal tumors in transgenic mice. Invest. Ophthalmol. Vis. Sci. 45, 764-768.
20. Wei Y., Gong J., Yoshida T., Eberhart C. G., Xu Z., Kombairaju P., Sporn M. B., Handa J. T., and, Duh E. J., (2011) Nrf2 has a protective role against neuronal and capillary degeneration in retinal ischemia-reperfusion injury. Free Radic. Biol. Med. 51, 216-224.
21. Welsbie D. S., Yang Z., Ge Y., et al,. (2013) Functional genomic screening identifies dual leucine zipper kinase as a key mediator of retinal ganglion cell death. Proc. Natl Acad. Sci. USA 110, 4045-4050.
22. Xu Z., Gong J., Maiti D., Vong L., Wu L., Schwarz J. J., and, Duh E. J., (2012) MEF2C ablation in endothelial cells reduces retinal vessel loss and suppresses pathologic retinal neovascularization in oxygen-induced retinopathy. Am. J. Pathol. 180, 2548-2560.
23. Xu Z., Wei Y., Gong J., et al,. (2014) NRF2 plays a protective role in diabetic retinopathy in mice. Diabetologia 57, 204-213.
24. Yokota H., Narayanan S. P., Zhang W., et al,. (2011) Neuroprotection from retinal ischemia/reperfusion injury by NOX2 NADPH oxidase deletion. Invest. Ophthalmol. Vis. Sci. 52, 8123-8131.
25. Zweier J. L., Flaherty J. T., and, Weisfeldt M. L., (1987) Direct measurement of free radical generation following reperfusion of ischemic myocardium. Proc. Natl Acad. Sci. USA 84, 1404-1407.